Ungefroren H - Search Results

1

Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.

Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, Ungefroren H. Schniewind B, et al. Among authors: ungefroren h. Int J Cancer. 2004 Mar 20;109(2):182-8. doi: 10.1002/ijc.11679. Int J Cancer. 2004. PMID: 14750167

2

Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.

Chen WB, Lenschow W, Tiede K, Fischer JW, Kalthoff H, Ungefroren H. Chen WB, et al. Among authors: ungefroren h. J Biol Chem. 2002 Sep 27;277(39):36118-28. doi: 10.1074/jbc.M203709200. Epub 2002 Jul 24. J Biol Chem. 2002. PMID: 12140283 Free article.

3

Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.

Sipos B, Weber D, Ungefroren H, Kalthoff H, Zühlsdorff A, Luther C, Török V, Klöppel G. Sipos B, et al. Among authors: ungefroren h. Int J Cancer. 2002 Dec 20;102(6):592-600. doi: 10.1002/ijc.10753. Int J Cancer. 2002. PMID: 12448000

4

Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.

Ungefroren H, Lenschow W, Chen WB, Faendrich F, Kalthoff H. Ungefroren H, et al. J Biol Chem. 2003 Mar 28;278(13):11041-9. doi: 10.1074/jbc.M300035200. Epub 2003 Jan 20. J Biol Chem. 2003. PMID: 12538652 Free article.

-B., Lenschow, W., Tiede, K., Fischer, J. W., Kalthoff, H., and Ungefroren, H. (2002) J. Biol. Chem. 277, 36118-36128). Here, we present evidence that the ability of TGF-beta 1 to induce BGN mRNA, in addition to Smads, requires p38 MAPK signaling, because 1) …

-B., Lenschow, W., Tiede, K., Fischer, J. W., Kalthoff, H., and Ungefroren, H. (2002) J. Biol. Chem. 277, 36118-36128). …

5

PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells.

Trauzold A, Schmiedel S, Sipos B, Wermann H, Westphal S, Röder C, Klapper W, Arlt A, Lehnert L, Ungefroren H, Johannes FJ, Kalthoff H. Trauzold A, et al. Among authors: ungefroren h. Oncogene. 2003 Dec 4;22(55):8939-47. doi: 10.1038/sj.onc.1207001. Oncogene. 2003. PMID: 14654790

6

Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.

Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fändrich F. Ungefroren H, et al. J Biol Chem. 2005 Jan 28;280(4):2644-52. doi: 10.1074/jbc.M411925200. Epub 2004 Nov 16. J Biol Chem. 2005. PMID: 15546867 Free article.

We have recently shown that induction of biglycan (BGN) expression by transforming growth factor-beta1 (TGF-beta1) required sequential activation of both Smad and p38 mitogen-activated protein kinase signaling (Ungefroren, H., Lenschow, W., Chen, W.-B., and Kalthoff …

We have recently shown that induction of biglycan (BGN) expression by transforming growth factor-beta1 (TGF-beta1) required sequential activ …

7

Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy.

Ruhnke M, Nussler AK, Ungefroren H, Hengstler JG, Kremer B, Hoeckh W, Gottwald T, Heeckt P, Fandrich F. Ruhnke M, et al. Among authors: ungefroren h. Transplantation. 2005 May 15;79(9):1097-103. doi: 10.1097/01.tp.0000157362.91322.82. Transplantation. 2005. PMID: 15880050

8

Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells.

Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schormann W, Hengstler JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch RM, Heeckt P, Kremer B, Fändrich F. Ruhnke M, et al. Among authors: ungefroren h. Gastroenterology. 2005 Jun;128(7):1774-86. doi: 10.1053/j.gastro.2005.03.029. Gastroenterology. 2005. PMID: 15940611

9

Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.

Groth S, Schulze M, Kalthoff H, Fändrich F, Ungefroren H. Groth S, et al. Among authors: ungefroren h. J Biol Chem. 2005 Sep 30;280(39):33190-9. doi: 10.1074/jbc.M504249200. Epub 2005 Jul 28. J Biol Chem. 2005. PMID: 16051607 Free article.

10

Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells.

Christgen M, Schniewind B, Jueschke A, Ungefroren H, Kalthoff H. Christgen M, et al. Among authors: ungefroren h. Cancer Lett. 2005 Sep 28;227(2):193-200. doi: 10.1016/j.canlet.2005.01.016. Cancer Lett. 2005. PMID: 16112422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters